Risk Factors for Immune Checkpoint Inhibitor-Induced Liver Injury and the Significance of Liver Biopsy
Immune checkpoint inhibitor (ICI)-induced liver injury (LI) is a common adverse event, but the clinical characteristics based on the classification of hepatocellular injury and cholestatic types are not fully evaluated. This study aims to analyze risk factors and histological findings in relation to...
| Published in: | Diagnostics |
|---|---|
| Main Authors: | , , , , , , , , , , |
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2024-04-01
|
| Subjects: | |
| Online Access: | https://www.mdpi.com/2075-4418/14/8/815 |
| _version_ | 1850059868337078272 |
|---|---|
| author | Miki Kawano Yoshihiko Yano Atsushi Yamamoto Eiichiro Yasutomi Yuta Inoue Jun Kitadai Ryutaro Yoshida Takanori Matsuura Yuuki Shiomi Yoshihide Ueda Yuzo Kodama |
| author_facet | Miki Kawano Yoshihiko Yano Atsushi Yamamoto Eiichiro Yasutomi Yuta Inoue Jun Kitadai Ryutaro Yoshida Takanori Matsuura Yuuki Shiomi Yoshihide Ueda Yuzo Kodama |
| author_sort | Miki Kawano |
| collection | DOAJ |
| container_title | Diagnostics |
| description | Immune checkpoint inhibitor (ICI)-induced liver injury (LI) is a common adverse event, but the clinical characteristics based on the classification of hepatocellular injury and cholestatic types are not fully evaluated. This study aims to analyze risk factors and histological findings in relation to the classification of ICI-induced LI. In total, 254 ICI-induced LI patients among 1086 treated with ICIs between September 2014 and March 2022 were classified according to the diagnostic criteria for drug-induced LI (DILI), and their risk factors and outcomes were evaluated. Kaplan–Meier analyses showed that overall survival in patients with hepatocellular-injury-type LI was significantly longer than others (<i>p</i> < 0.05). Regarding pre-treatment factors, the lymphocyte count was significantly higher in patients with ICI-induced LI, especially in hepatocellular-injury-type LI. Gamma glutamyl transferase (γGTP) and alkaline phosphatase (ALP) were also significantly lower in patients with ICI-induced LI (<i>p</i> < 0.05). Multivariate analyses revealed that malignant melanoma, high lymphocyte count, and low ALP levels were extracted as factors contributing to hepatocellular-injury-type LI. The histological findings among 37 patients diagnosed as ICI-induced LI via liver biopsy also revealed that the spotty/focal necrosis was significantly frequent in hepatocellular-injury-type LI, whereas ductular reactions were frequently observed in cholestatic-type LI. It is suggested that the histological inflammation pattern in patients with LI is closely correlated with the type of DILI. |
| format | Article |
| id | doaj-art-e9709c65e4fb4d12ae4cd493d1f2cfae |
| institution | Directory of Open Access Journals |
| issn | 2075-4418 |
| language | English |
| publishDate | 2024-04-01 |
| publisher | MDPI AG |
| record_format | Article |
| spelling | doaj-art-e9709c65e4fb4d12ae4cd493d1f2cfae2025-08-20T00:22:36ZengMDPI AGDiagnostics2075-44182024-04-0114881510.3390/diagnostics14080815Risk Factors for Immune Checkpoint Inhibitor-Induced Liver Injury and the Significance of Liver BiopsyMiki Kawano0Yoshihiko Yano1Atsushi Yamamoto2Eiichiro Yasutomi3Yuta Inoue4Jun Kitadai5Ryutaro Yoshida6Takanori Matsuura7Yuuki Shiomi8Yoshihide Ueda9Yuzo Kodama10Division of Gastroenterology, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe 650-0017, JapanDivision of Gastroenterology, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe 650-0017, JapanDivision of Gastroenterology, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe 650-0017, JapanDepartment of Gastroenterology, Hyogo Prefectural Kakogawa Medical Center, Kakogawa 675-8555, JapanDivision of Gastroenterology, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe 650-0017, JapanDivision of Gastroenterology, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe 650-0017, JapanDivision of Gastroenterology, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe 650-0017, JapanDivision of Gastroenterology, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe 650-0017, JapanDivision of Gastroenterology, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe 650-0017, JapanDivision of Gastroenterology, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe 650-0017, JapanDivision of Gastroenterology, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe 650-0017, JapanImmune checkpoint inhibitor (ICI)-induced liver injury (LI) is a common adverse event, but the clinical characteristics based on the classification of hepatocellular injury and cholestatic types are not fully evaluated. This study aims to analyze risk factors and histological findings in relation to the classification of ICI-induced LI. In total, 254 ICI-induced LI patients among 1086 treated with ICIs between September 2014 and March 2022 were classified according to the diagnostic criteria for drug-induced LI (DILI), and their risk factors and outcomes were evaluated. Kaplan–Meier analyses showed that overall survival in patients with hepatocellular-injury-type LI was significantly longer than others (<i>p</i> < 0.05). Regarding pre-treatment factors, the lymphocyte count was significantly higher in patients with ICI-induced LI, especially in hepatocellular-injury-type LI. Gamma glutamyl transferase (γGTP) and alkaline phosphatase (ALP) were also significantly lower in patients with ICI-induced LI (<i>p</i> < 0.05). Multivariate analyses revealed that malignant melanoma, high lymphocyte count, and low ALP levels were extracted as factors contributing to hepatocellular-injury-type LI. The histological findings among 37 patients diagnosed as ICI-induced LI via liver biopsy also revealed that the spotty/focal necrosis was significantly frequent in hepatocellular-injury-type LI, whereas ductular reactions were frequently observed in cholestatic-type LI. It is suggested that the histological inflammation pattern in patients with LI is closely correlated with the type of DILI.https://www.mdpi.com/2075-4418/14/8/815immune checkpoint inhibitorliver injuryDILIhistology |
| spellingShingle | Miki Kawano Yoshihiko Yano Atsushi Yamamoto Eiichiro Yasutomi Yuta Inoue Jun Kitadai Ryutaro Yoshida Takanori Matsuura Yuuki Shiomi Yoshihide Ueda Yuzo Kodama Risk Factors for Immune Checkpoint Inhibitor-Induced Liver Injury and the Significance of Liver Biopsy immune checkpoint inhibitor liver injury DILI histology |
| title | Risk Factors for Immune Checkpoint Inhibitor-Induced Liver Injury and the Significance of Liver Biopsy |
| title_full | Risk Factors for Immune Checkpoint Inhibitor-Induced Liver Injury and the Significance of Liver Biopsy |
| title_fullStr | Risk Factors for Immune Checkpoint Inhibitor-Induced Liver Injury and the Significance of Liver Biopsy |
| title_full_unstemmed | Risk Factors for Immune Checkpoint Inhibitor-Induced Liver Injury and the Significance of Liver Biopsy |
| title_short | Risk Factors for Immune Checkpoint Inhibitor-Induced Liver Injury and the Significance of Liver Biopsy |
| title_sort | risk factors for immune checkpoint inhibitor induced liver injury and the significance of liver biopsy |
| topic | immune checkpoint inhibitor liver injury DILI histology |
| url | https://www.mdpi.com/2075-4418/14/8/815 |
| work_keys_str_mv | AT mikikawano riskfactorsforimmunecheckpointinhibitorinducedliverinjuryandthesignificanceofliverbiopsy AT yoshihikoyano riskfactorsforimmunecheckpointinhibitorinducedliverinjuryandthesignificanceofliverbiopsy AT atsushiyamamoto riskfactorsforimmunecheckpointinhibitorinducedliverinjuryandthesignificanceofliverbiopsy AT eiichiroyasutomi riskfactorsforimmunecheckpointinhibitorinducedliverinjuryandthesignificanceofliverbiopsy AT yutainoue riskfactorsforimmunecheckpointinhibitorinducedliverinjuryandthesignificanceofliverbiopsy AT junkitadai riskfactorsforimmunecheckpointinhibitorinducedliverinjuryandthesignificanceofliverbiopsy AT ryutaroyoshida riskfactorsforimmunecheckpointinhibitorinducedliverinjuryandthesignificanceofliverbiopsy AT takanorimatsuura riskfactorsforimmunecheckpointinhibitorinducedliverinjuryandthesignificanceofliverbiopsy AT yuukishiomi riskfactorsforimmunecheckpointinhibitorinducedliverinjuryandthesignificanceofliverbiopsy AT yoshihideueda riskfactorsforimmunecheckpointinhibitorinducedliverinjuryandthesignificanceofliverbiopsy AT yuzokodama riskfactorsforimmunecheckpointinhibitorinducedliverinjuryandthesignificanceofliverbiopsy |
